Melanoma (Skin Cancer) research hub

Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLC

This study looks at combining two drugs, bexmarilimab and nivolumab, for advanced skin and lung cancers. It aims to find a safe dose and see if this combination can help when previous immunotherapy stopped working.